Congratulations Dr. Nikolaus McFarland on the publication of “Automated MRI Classification in Progressive Supranuclear Palsy: a Large International Cohort Study,” in the February issue of Movement Disorders.
Abstract
Background
The Magnetic Resonance Parkinsonism Index is listed as one of the most reliable imaging morphometric markers for diagnosis of progressive supranuclear palsy (PSP). However, the use of this index in diagnostic workup has been limited until now by the low generalizability of published results because of small monocentric patient cohorts, the lack of data validation in independent patient series, and manual measurements used for index calculation. The objectives of this study were to investigate the generalizability of Magnetic Resonance Parkinsonism Index performance validating previously established cutoff values in a large international cohort of PSP patients subclassified into PSP–Richardson’s syndrome and PSP‐parkinsonism and to standardize the use of the automated Magnetic Resonance Parkinsonism Index by providing a web‐based platform to obtain homogenous measures around the world.
Methods
In a retrospective international multicenter study, a total of 173 PSP patients and 483 non‐PSP participants were enrolled. A web‐based platform was used to calculate automated Magnetic Resonance Parkinsonism Index values.
Results
Magnetic Resonance Parkinsonism Index values showed optimal performance in differentiating PSP–Richardson’s syndrome and PSP‐parkinsonism patients from non‐PSP participants (93.6% and 86.5% of accuracy, respectively). The Magnetic Resonance Parkinsonism Index was also able to differentiate PSP–Richardson’s syndrome and PSP‐parkinsonism patients in an early stage of the disease from non‐PSP participants (90.1% and 85.9%, respectively). The web‐based platform provided the automated Magnetic Resonance Parkinsonism Index calculation in 94% of cases.
Conclusions
Our study provides the first evidence on the generalizability of automated Magnetic Resonance Parkinsonism Index measures in a large international cohort of PSP–Richardson’s syndrome and PSP‐parkinsonism patients. The web‐based platform enables widespread applicability of the automated Magnetic Resonance Parkinsonism Index to different clinical and research settings. © 2020 International Parkinson and Movement Disorder Society